Which laboratory finding is most consistent with hyperammonemia-related encephalopathy?

Study for the NCLEX Hepatic and Biliary Exam. Enhance your knowledge with flashcards and multiple choice questions, featuring hints and explanations. Get prepared and boost your confidence for test day!

Multiple Choice

Which laboratory finding is most consistent with hyperammonemia-related encephalopathy?

Explanation:
Hyperammonemia causes encephalopathy by the brain’s exposure to ammonia, a toxic metabolite that is normally detoxified by the liver. When ammonia accumulates, it crosses the blood-brain barrier and is taken up by astrocytes, where it is converted to glutamine. This leads to astrocyte swelling, cerebral edema, and impaired neurotransmission, producing the cognitive and personality changes, confusion, or coma seen in hepatic encephalopathy. Therefore, the most consistent laboratory finding is an elevated serum ammonia level. Other labs reflect liver injury or metabolic status but not the specific neurotoxic process. Elevated glucose can occur with illness but doesn’t indicate ammonia toxicity. Elevated bilirubin signals cholestasis or hepatocellular injury but doesn’t directly measure encephalopathy risk. Low albumin points to chronic liver dysfunction and reduced synthetic function, not the acute neurotoxic state.

Hyperammonemia causes encephalopathy by the brain’s exposure to ammonia, a toxic metabolite that is normally detoxified by the liver. When ammonia accumulates, it crosses the blood-brain barrier and is taken up by astrocytes, where it is converted to glutamine. This leads to astrocyte swelling, cerebral edema, and impaired neurotransmission, producing the cognitive and personality changes, confusion, or coma seen in hepatic encephalopathy. Therefore, the most consistent laboratory finding is an elevated serum ammonia level.

Other labs reflect liver injury or metabolic status but not the specific neurotoxic process. Elevated glucose can occur with illness but doesn’t indicate ammonia toxicity. Elevated bilirubin signals cholestasis or hepatocellular injury but doesn’t directly measure encephalopathy risk. Low albumin points to chronic liver dysfunction and reduced synthetic function, not the acute neurotoxic state.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy